Cargando…

Resistance of Human Liver Mesenchymal Stem Cells to FAS-Induced Cell Death

Mesenchymal stem cells (MSCs) have a pronounced therapeutic potential in various pathological conditions. Though therapeutic effects of MSC transplantation have been studied for a long time, the underlying mechanisms are still not clear. It has been shown that transplanted MSCs are rapidly eliminate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kholodenko, Irina V., Gisina, Alisa M., Manukyan, Garik V., Majouga, Alexander G., Svirshchevskaya, Elena V., Kholodenko, Roman V., Yarygin, Konstantin N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406952/ https://www.ncbi.nlm.nih.gov/pubmed/36005132 http://dx.doi.org/10.3390/cimb44080236

Ejemplares similares

Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope?
por: Kholodenko, Irina V., et al.
Publicado: (2019)

The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress
por: Kholodenko, Irina V., et al.
Publicado: (2023)

Glioma Stem Cells: Novel Data Obtained by Single-Cell Sequencing
por: Gisina, Alisa, et al.
Publicado: (2022)

Apoptotic MSCs and MSC-Derived Apoptotic Bodies as New Therapeutic Tools
por: Kholodenko, Irina V., et al.
Publicado: (2022)

Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood–Brain Barrier?
por: Yarygin, Konstantin N., et al.
Publicado: (2021)

Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases
por: Kholodenko, Irina V., et al.
Publicado: (2017)

Cell-based therapies of liver diseases: age-related challenges
por: Yarygin, Konstantin N, et al.
Publicado: (2015)

TRIM28 Is a Novel Regulator of CD133 Expression Associated with Cancer Stem Cell Phenotype
por: Kim, Yan S., et al.
Publicado: (2022)

Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
por: Kholodenko, Irina V., et al.
Publicado: (2023)

Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4
por: Kalinovsky, Daniel V., et al.
Publicado: (2023)

Ganglioside GD2 in reception and transduction of cell death signal in tumor cells
por: Doronin, Igor I, et al.
Publicado: (2014)

Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells
por: Kalinovsky, Daniel V., et al.
Publicado: (2023)

Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies
por: V. Kholodenko, Irina, et al.
Publicado: (2019)

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors
por: Kalinovsky, Daniel V, et al.
Publicado: (2022)

Methodological aspects of MRI of transplanted superparamagnetic iron oxide-labeled mesenchymal stem cells in live rat brain
por: Namestnikova, Daria, et al.
Publicado: (2017)

Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway
por: Atsuta, Ikiru, et al.
Publicado: (2013)

Neuroblastoma Origin and Therapeutic Targets for Immunotherapy
por: Kholodenko, Irina V., et al.
Publicado: (2018)

Impairment of Fas-ligand–caveolin-1 interaction inhibits Fas-ligand translocation to rafts and Fas-ligand-induced cell death
por: Glukhova, Xenia A., et al.
Publicado: (2018)

Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin
por: García-Santos, G, et al.
Publicado: (2012)

Chlorin e6 Phospholipid Delivery System Featuring APN/CD13 Targeting Peptides: Cell Death Pathways, Cell Localization, In Vivo Biodistribution
por: Tereshkina, Yulia A., et al.
Publicado: (2022)

Fas-L promotes the stem cell potency of adipose-derived mesenchymal cells
por: Solodeev, Inna, et al.
Publicado: (2018)

Modulation of Cell Death and Promotion of Chondrogenic Differentiation by Fas/FasL in Human Dental Pulp Stem Cells (hDPSCs)
por: Pisciotta, Alessandra, et al.
Publicado: (2020)

Combined Cell Therapy in the Treatment of Neurological Disorders
por: Namestnikova, Daria D., et al.
Publicado: (2020)

Heterotypic Multicellular Spheroids as Experimental and Preclinical Models of Sprouting Angiogenesis
por: Vakhrushev, Igor V., et al.
Publicado: (2021)

Hydrogen sulfide promotes immunomodulation of gingiva-derived mesenchymal stem cells via the Fas/FasL coupling pathway
por: Yang, Ruili, et al.
Publicado: (2018)

Osthole enhances the immunosuppressive effects of bone marrow‐derived mesenchymal stem cells by promoting the Fas/FasL system
por: Yu, Yang, et al.
Publicado: (2021)

Telomeres and Telomerase in the Control of Stem Cells
por: Lupatov, Alexey Yu., et al.
Publicado: (2022)

CD70–CD27 ligation between neural stem cells and CD4(+) T cells induces Fas–FasL-mediated T-cell death
por: Lee, Eun Mi, et al.
Publicado: (2013)

Cell Death in AMD: The Rationale for Targeting Fas
por: Zacks, David N., et al.
Publicado: (2022)

Mesenchymal stem cells with irreversibly arrested proliferation stimulate decidua development in rats
por: Domnina, Alisa P., et al.
Publicado: (2016)

Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression
por: Chen, Chider, et al.
Publicado: (2014)

Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death
por: D'Souza, Sameer D., et al.
Publicado: (1996)

Naja atra Cardiotoxin 1 Induces the FasL/Fas Death Pathway in Human Leukemia Cells
por: Chiou, Jing-Ting, et al.
Publicado: (2021)

TNFα sensitizes neuroblastoma cells to FasL-, cisplatin- and etoposide-induced cell death by NF-κB-mediated expression of Fas
por: Galenkamp, Koen MO, et al.
Publicado: (2015)

The Effects of Programmed Cell Death of Mesenchymal Stem Cells on the Development of Liver Fibrosis
por: Wu, Hong-wei, et al.
Publicado: (2023)

Mesenchymal Stem Cell-Based Therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders
por: Issa, Shaza S., et al.
Publicado: (2022)

CART cells are prone to Fas- and DR5-mediated cell death
por: Tschumi, Benjamin O., et al.
Publicado: (2018)

Programmed Cell Death of Embryonic Motoneurons Triggered through the FAS Death Receptor
por: Raoul, Cédric, et al.
Publicado: (1999)

Mesenchymal Stromal Cells Isolated from Ectopic but Not Eutopic Endometrium Display Pronounced Immunomodulatory Activity In Vitro
por: Lupatov, Alexey Yu., et al.
Publicado: (2021)

Dynamic MRI of the Mesenchymal Stem Cells Distribution during Intravenous Transplantation in a Rat Model of Ischemic Stroke
por: Cherkashova, Elvira A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p9f16molk76dlo3uff1hf938g2